AbstractMany chemotherapeutic compounding units are confronted with the problem of product delivery to different care wards. We think that transport by a pharmacy agent does not permit appropriate traceability (wrong care service delivery), control of storage temperature and management of urgency. We have developed a delivery system based on the association of a pneumatic transport system (PTS) and monitored buffer storage area. Thus, after pharmaceutical inspection, chemotherapies are placed in specific and hermetic carriers in the PTS but not directly delivered to care units. In the monitored buffer storage, a robotic arm organizes chemotherapies and waits for the nurse call just before administration. This system permits a real traceability for each stage of the chemotherapy circuit and so, we are now able to certify that chemotherapeutics have been maintained at the correct temperature through continual monitoring. It’s an important prerequisite in standardization and reassignment. Finally, an important issue linked to the use of PTS is the risk of damaging the chemotherapeutics. Data obtained from literature and manufacturers for antibodies highlight the low risk to use a PTS.
The most prevalent pathology was lung cancer (19 CT, 14 of which were non-small cell lung cancer) and melanoma (four CT). Conclusion The CT are an opportunity to contain pharmaceutical costs in hospitals. Patients in CT produced a cost saving of C ¼ 3,482,662/year. The potential savings justify the need to incorporate as many clinical trials as possible, not just for cost savings but because it would mean better access for patients to these highly effective and/or breakthrough therapies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.